Ryan Cos. plans Minneapolis headquarters move Ryan Cos. US Inc. plans to moves its headquarters to a new building near U.S. Bank Stadium in Minneapolis.
The developer will build a four-story, 172,000-square foot building at 513 S. Third St. and take about 55,000 square feet for its own offices.
About 275 Ryan Cos. employees will move from the current headquarters on Nicollet Mall to the new Downtown East property, which will be called the Millwright Building.
Ryan expects to start construction on the project in the spring and be done by spring…
Mon, 30 Nov 2015 16:38:21 +0000 OSHA: Atlanta construction company exposed workers to falls The Occupational Safety and Health Administration (OSHA) fined Atlanta-based JA Siding Construction Services LLC $65,120 for several alleged safety violations.
The citations included failure to provide fall protection equipment to employees working on a scaffold 28 to 32 feet high and failure to ensure the scaffold was properly secured, OSHA said. The company also failed to provide protective eyewear to workers using nail guns, according to OSHA. JA Siding was previously cited for this violation…
Mon, 30 Nov 2015 16:37:38 +0000 Monsanto venture unit invests in Spanish biotech company The venture capital arm of agribusiness giant Monsanto Co. recently joined a $6 million Series A round of financing for a Spanish biotech company.
According to private equity news source FinSMEs, Monsanto Growth Ventures led the investment in the Madrid-based Plant Response Biotech, which aims to identify and develop molecules and traits that regulate plant responses to stress.
Also joining the financing round were Caixa Capital Risc, Middleland Capital, and Novozymes, the latter of which has partnered…
Mon, 30 Nov 2015 16:37:00 +0000 UC system joins Gates, Bezos in investing in clean energy coalition The University of California will join Bill Gates and 28 investors from 10 other countries as part of an international coalition to boost investing in clean energy technology.
Investors including Gates, LinkedIn (NYSE: LNKD) founder Reid Hoffman and Amazon (Nasdaq: AMZN) founder Jeff Bezos have committed billions to the new project, dubbed the Breakthrough Energy Coalition, with Gates putting up $1 billion of his own money to stake the initiative.
“The UC system — with its world-leading campuses…
Mon, 30 Nov 2015 16:34:29 +0000 Most popular BioFlash stories from November: It’s all about the battle in Duchenne In the weeks leading up to the Nov. 24 FDA advisory committee hearing on the potential drug for Duchenne muscular dystrophy by BioMarin Pharmaceuticals, it’s no surprise that five of the top 10 most-read stories from the BioFlash newsletter during the month were related to what’s currently the most-watched battle in all of biotech.
California-based BioMarin (Nasdaq: BMRN) and Cambridge-based Sarepta Therapeutics (Nasdaq: SRPT) are locked in a race for the first drug to treat the disease in the…
Mon, 30 Nov 2015 16:33:57 +0000 Foulston Siefkin adds attorneys Foulston Siefkin has hired two new associate attorneys.
Trent Byguist and Kelsey Frobisher are the firm's newest additions.
Byquist’s practice involves business and corporate law, mergers and acquisitions, franchise and distribution and agribusiness. He joined Foulston Siefkin after spending two years as a law clerk for Lawton R. Nuss, chief justice of the Supreme Court of Kansas.
He is a graduate of the University of Kansas School of Law and has a bachelor's degree from Kansas State University,…
Mon, 30 Nov 2015 16:33:35 +0000 In the money: Major funding for St. Louis startups in November November turned out to be a good month for St. Louis’ startup and innovation community.
A handful of major funding deals, acquisitions and IPOs took place.
Those included deals such as Varsity Tutors’ $57 million financing and a better-than-expected public debut for Square, which increased the value of two native St. Louisans’ stake in the multibillion-dollar company.
Click on the photos to learn more about who got money in November.
Mon, 30 Nov 2015 16:33:31 +0000 Idera Pharma shares hit 8-month high on new blood, new look and pending trial data Heading into a key presentation of mid-stage trial results this weekend from a potential blood cancer drug in the spotlight of one of the biggest biotech stages of the year, Idera Pharmaceuticals this morning named four new executives from big-name companies to its team.
Shares of Cambridge-based Idera (Nasdaq: IDRA) were up 10 percent today as of late morning, trading above $4 for the first time since March. The company’s market value was $482 million as of 11:20 a.m. The increase was helped…
Mon, 30 Nov 2015 16:32:24 +0000
Not receiving our weekly updates? You are missing out!
Click & "Like Us" On FaceBook
Let Us Learn and Do Business
Enhancing peoples lives professionally and personally by providing the connections of strategic alliances of like-minded people. Creating growth and development through mentoring and education.